Impact of the donor body mass index on the survival of pediatric liver transplant recipients and Post‐transplant obesity

Emily Rothbaum Perito, Sue Rhee, Dave Glidden, John Paul Roberts, Philip Rosenthal – 29 March 2012 – In adult liver transplant recipients, the donor body mass index (dBMI) is associated with posttransplant obesity but not with graft or patient survival. Because of the obesity epidemic in the United States and the already limited supply of liver donors, clarifying whether the dBMI affects pediatric outcomes is important. United Network for Organ Sharing data for pediatric liver transplants in the United States (1990‐2010) were evaluated.

Long‐term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation

John K. O'Connor, James Trotter, Gary L. Davis, Jane Dempster, Goran B. Klintmalm, Robert M. Goldstein – 29 March 2012 – Hepatocellular carcinoma (HCC) is potentially curable with hepatic resection or transplantation. Few patients are eligible for resection, and many face a long wait for donor organ availability for liver transplantation. Here we report the safety and efficacy of stereotactic body radiation therapy (SBRT), the explant pathology findings and survival of patients treated with SBRT as a bridge to transplantation for HCC.

Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease

Valerio Nobili, Guido Carpino, Anna Alisi, Antonio Franchitto, Gianfranco Alpini, Rita De Vito, Paolo Onori, Domenico Alvaro, Eugenio Gaudio – 29 March 2012 – Hepatic progenitor cells (HPCs) play a major role in liver repair and regeneration. We evaluated HPC involvement in pediatric nonalcoholic fatty liver disease (pNAFLD). Thirty biopsies of consecutive children and adolescents with untreated NAFLD (19 with nonalcoholic steatohepatitis [NASH] and 11 without NASH) were studied using immunohistochemistry and immunofluorescence.

Mechanism of tissue‐specific farnesoid X receptor in suppressing the expression of genes in bile‐acid synthesis in mice

Bo Kong, Li Wang, John Y.L. Chiang, Youcai Zhang, Curtis D. Klaassen, Grace L. Guo – 29 March 2012 – Activation of farnesoid X receptor (Fxr, Nr1h4) is a major mechanism in suppressing bile‐acid synthesis by reducing the expression levels of genes encoding key bile‐acid synthetic enzymes (e.g., cytochrome P450 [CYP]7A1/Cyp7a1 and CYP8B1/Cyp8b1). FXR‐mediated induction of hepatic small heterodimer partner (SHP/Shp, Nr0b2) and intestinal fibroblast growth factor 15 (Fgf15; FGF19 in humans) has been shown to be responsible for this suppression.

Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection

Sylvie Lagaye, Hong Shen, Bertrand Saunier, Michelina Nascimbeni, Jesintha Gaston, Pierre Bourdoncle, Laurent Hannoun, Pierre‐Philippe Massault, Anaïs Vallet‐Pichard, Vincent Mallet, Stanislas Pol – 27 March 2012 – The development of human cultured hepatitis C virus (HCV) replication‐permissive hepatocarcinoma cell lines has provided important new virological tools to study the mechanisms of HCV infection; however, this experimental model remains distantly related to physiological and pathological conditions.

Association of AKI With mortality and complications in hospitalized patients with cirrhosis

Justin M. Belcher, Guadalupe Garcia‐Tsao, Arun J. Sanyal, Harjit Bhogal, Joseph K. Lim, Naheed Ansari, Steven G. Coca, Chirag R. Parikh, for the TRIBE‐AKI Consortium – 27 March 2012 – Acute kidney injury (AKI) is a common and devastating complication in patients with cirrhosis. However, the definitions of AKI employed in studies involving patients with cirrhosis have not been standardized, lack sensitivity, and are often limited to narrow clinical settings.

Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation

See Ching Chan, Sheung Tat Fan, Kenneth S. H. Chok, William W. Sharr, Wing Chiu Dai, James Y. Y. Fung, Kwok Yin Chan, Dharmesh J. Balsarkar, Chung Mau Lo – 27 March 2012 – In living donor liver transplantation (LDLT), a right liver graft is larger than a left liver graft and hence leads to better recipient survival. However, in comparison with donor left hepatectomy, donor right hepatectomy carries a higher donor risk.

Subscribe to